NL23522C
(ko)
|
1927-03-23 |
|
|
|
US4634665A
(en)
|
1980-02-25 |
1987-01-06 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US5179017A
(en)
|
1980-02-25 |
1993-01-12 |
The Trustees Of Columbia University In The City Of New York |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
IL63224A
(en)
|
1980-07-17 |
1985-05-31 |
Scripps Clinic Res |
Synthetic peptide specific antigenic determinant and method of manufacturing antigenic materials therefrom
|
IL61904A
(en)
|
1981-01-13 |
1985-07-31 |
Yeda Res & Dev |
Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
|
US4475196A
(en)
|
1981-03-06 |
1984-10-02 |
Zor Clair G |
Instrument for locating faults in aircraft passenger reading light and attendant call control system
|
US4447233A
(en)
|
1981-04-10 |
1984-05-08 |
Parker-Hannifin Corporation |
Medication infusion pump
|
US4439196A
(en)
|
1982-03-18 |
1984-03-27 |
Merck & Co., Inc. |
Osmotic drug delivery system
|
US4625015A
(en)
|
1982-08-23 |
1986-11-25 |
Scripps Clinic & Research Foundation |
Broad spectrum influenza antisera
|
ZA836080B
(en)
|
1982-08-23 |
1984-04-25 |
Scripps Clinic Res |
Broad spectrum influenza antisera
|
US4447224A
(en)
|
1982-09-20 |
1984-05-08 |
Infusaid Corporation |
Variable flow implantable infusion apparatus
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
US4486194A
(en)
|
1983-06-08 |
1984-12-04 |
James Ferrara |
Therapeutic device for administering medicaments through the skin
|
US4596556A
(en)
|
1985-03-25 |
1986-06-24 |
Bioject, Inc. |
Hypodermic injection apparatus
|
JP2518607B2
(ja)
|
1985-08-29 |
1996-07-24 |
雪印乳業株式会社 |
インフルエンザa型ウイルスha抗原に対するモノクロ―ナル抗体およびその作成方法
|
WO1988006882A1
(en)
|
1987-03-13 |
1988-09-22 |
Micro Vesicular Systems, Inc. |
Lipid vesicles formed of surfactants and steroids
|
US4941880A
(en)
|
1987-06-19 |
1990-07-17 |
Bioject, Inc. |
Pre-filled ampule and non-invasive hypodermic injection device assembly
|
US4790824A
(en)
|
1987-06-19 |
1988-12-13 |
Bioject, Inc. |
Non-invasive hypodermic injection device
|
WO1989011298A1
(en)
|
1988-05-27 |
1989-11-30 |
Centocor, Inc. |
Formulation for antibody reagents
|
US5312335A
(en)
|
1989-11-09 |
1994-05-17 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5064413A
(en)
|
1989-11-09 |
1991-11-12 |
Bioject, Inc. |
Needleless hypodermic injection device
|
US5383851A
(en)
|
1992-07-24 |
1995-01-24 |
Bioject Inc. |
Needleless hypodermic injection device
|
US5589174A
(en)
|
1992-09-17 |
1996-12-31 |
Takara Shuzo Co., Ltd. |
Anti-human influenza virus antibody
|
US6337070B1
(en)
|
1993-04-29 |
2002-01-08 |
Takara Shuzo Co., Ltd. |
Polypeptides for use in generating anti-human influenza virus antibodies
|
GB9320597D0
(en)
|
1993-10-06 |
1993-11-24 |
Proteus Molecular Design |
Improvements in and realting to vaccines
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
JP2996864B2
(ja)
|
1994-03-30 |
2000-01-11 |
寳酒造株式会社 |
抗体可変領域dna
|
DE19643314A1
(de)
|
1996-10-21 |
1998-04-23 |
Boehringer Mannheim Gmbh |
Monoklonale Antikörper gegen das Epitop YPYDVPDYA, Verfahren zu deren Herstellung und Verwendung
|
FR2817869B1
(fr)
|
2000-12-07 |
2005-01-14 |
Technopharm |
Anticorps monoclonal humain dirige contre le virus influenza ou un fragment de celui-ci
|
DK2345671T3
(en)
|
2002-09-27 |
2016-02-15 |
Xencor Inc |
Optimized Fc variants and methods for their formation
|
KR101130181B1
(ko)
|
2003-02-27 |
2012-03-28 |
예다 리서치 앤드 디벨럽먼트 캄파니 리미티드 |
인플루엔자 바이러스 감염의 치료 및 검출에 유용한 핵산분자, 폴리펩티드, 항체 및 이를 포함하는 조성물
|
WO2005018539A2
(en)
|
2003-06-16 |
2005-03-03 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
AU2004277466C1
(en)
|
2003-10-01 |
2022-06-23 |
Kyowa Kirin Co., Ltd. |
Method of stabilizing antibody and stabilized solution-type antibody preparation
|
PT2261376E
(pt)
|
2003-11-04 |
2013-09-23 |
Univ Tulane |
Método para prevenir a fusão vírus:células inibindo a função da região de iniciação de fusão em vírus de rna tendo proteínas do invólucro fusogénicas de membrana de classe i
|
AU2004290070A1
(en)
|
2003-11-12 |
2005-05-26 |
Biogen Idec Ma Inc. |
Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
|
WO2005063815A2
(en)
|
2003-11-12 |
2005-07-14 |
Biogen Idec Ma Inc. |
Fcϝ receptor-binding polypeptide variants and methods related thereto
|
WO2005116270A2
(en)
|
2004-05-18 |
2005-12-08 |
Vical Incorporated |
Influenza virus vaccine composition and method of use
|
WO2005116260A2
(en)
|
2004-05-25 |
2005-12-08 |
Medimmune Vaccines, Inc. |
Influenza hemagglutinin and neuraminidase variants
|
CA2591992A1
(en)
*
|
2004-12-22 |
2006-06-29 |
The Salk Institute For Biological Studies |
Compositions and methods for producing recombinant proteins
|
US7572620B2
(en)
|
2005-01-11 |
2009-08-11 |
Wisconsin Alumni Research Foundation |
H3 equine influenza A virus
|
CA2598884A1
(en)
|
2005-02-24 |
2006-10-05 |
University Of Massachusetts |
Influenza nucleic acids, polypeptides, and uses thereof
|
CA2637837A1
(en)
*
|
2006-01-26 |
2007-08-09 |
Hx Diagnostics, Inc. |
Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof
|
US8222204B2
(en)
|
2006-05-03 |
2012-07-17 |
The Administrators of the Tulane Educational Fund and Autoimmune Technologies, LLC |
Influenza inhibiting compositions and methods
|
US20080014205A1
(en)
|
2006-05-15 |
2008-01-17 |
Lawrence Horowitz |
Neutralizing Antibodies to Influenza Viruses
|
BRPI0713671A2
(pt)
|
2006-06-16 |
2013-12-03 |
Dow Agrosciences Llc |
Sequências de dna, vetores e proteínas de hemaglutinina de influenza aviária
|
WO2008028946A2
(en)
|
2006-09-07 |
2008-03-13 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
|
US20100150941A1
(en)
|
2006-09-13 |
2010-06-17 |
Dso National Laboratories |
Hemagglutinin antibody and uses thereof
|
JP4625485B2
(ja)
|
2006-09-29 |
2011-02-02 |
財団法人大阪産業振興機構 |
高病原性トリインフルエンザウイルスに対するモノクローナル抗体
|
US8030029B2
(en)
|
2007-01-23 |
2011-10-04 |
Academia Sinica |
Flu vaccines and methods of use thereof
|
JP5346820B2
(ja)
|
2007-03-13 |
2013-11-20 |
エイチユーエムエイビーエス・リミテッド・ライアビリティ・カンパニー |
H5n1亜型a型インフルエンザウィルスに対する抗体
|
JP5779350B2
(ja)
|
2007-03-27 |
2015-09-16 |
シー レーン バイオテクノロジーズ, エルエルシー |
抗体代替軽鎖配列を含む構築物およびライブラリー
|
EP2155787A4
(en)
|
2007-05-11 |
2010-06-16 |
Temasek Life Sciences Lab Ltd |
SPECIFIC TO THE H5-SUBTYPE BINDING PROTEINS SUITED TO THE DIAGNOSIS AND MONITORING OF THE H5 BIRGRAP
|
BRPI0811857A2
(pt)
|
2007-05-14 |
2014-10-21 |
Biogen Idec Inc |
Regiões fc (scfc) de cadeia simples, polipeptídeos de aglutinação que as compreendem e métodos relacionados.
|
EP2716656B1
(en)
|
2007-06-15 |
2016-10-12 |
Xiamen University |
Monoclonal antibodies binding to avian influenza virus subtype H5 haemagglutinin and uses thereof
|
WO2008156763A2
(en)
|
2007-06-15 |
2008-12-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Human neutralizing monoclonal antibodies to h5n1 influenza a virus
|
AU2008297594B2
(en)
|
2007-09-13 |
2013-06-20 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus H5-subtype or N1-subtype and uses thereof
|
WO2009035412A1
(en)
|
2007-09-13 |
2009-03-19 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof
|
FR2921928B1
(fr)
|
2007-10-08 |
2011-03-04 |
Sanofi Pasteur |
Anticorps monoclonaux specifiques de l'hemagglutinine du virus grippal
|
JP5705545B2
(ja)
|
2007-11-12 |
2015-04-22 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
インフルエンザウイルスの複数のサブタイプに対する新規ワクチン
|
WO2009073163A1
(en)
|
2007-12-03 |
2009-06-11 |
American Type Culture Collection (Atcc) |
Avian influenza antibodies, compositions, and methods thereof
|
US20110038935A1
(en)
|
2007-12-06 |
2011-02-17 |
Marasco Wayne A |
Antibodies against influenza virus and methods of use thereof
|
US7981428B2
(en)
|
2008-01-23 |
2011-07-19 |
Academia Sinica |
Flu vaccines and methods of use thereof
|
EP2250197B1
(en)
|
2008-02-05 |
2016-05-11 |
Temasek Life Sciences Laboratory Limited |
Binding protein and epitope-blocking elisa for the universal detection of h5-subtype influenza viruses
|
US8669046B2
(en)
|
2008-03-12 |
2014-03-11 |
Xuguang (Sean) Li |
Reagents and methods for detecting influenza virus proteins
|
ITTO20080204A1
(it)
|
2008-03-17 |
2009-09-18 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a
|
US8658354B2
(en)
|
2008-03-28 |
2014-02-25 |
National University Corporation Hokkaido University |
Anti-(influenza a virus subtype H5 hemagglutinin) monoclonal antibody
|
AU2009228058A1
(en)
|
2008-03-28 |
2009-10-01 |
Sea Lane Biotechnologies, Llc |
Neutralizing molecules to viral antigens
|
FI20080333A0
(fi)
|
2008-05-02 |
2008-05-02 |
Glykos Finland Oy |
Influenssaviruksen nukleiinihappoja ja peptidejä
|
ITTO20080398A1
(it)
|
2008-05-27 |
2009-11-28 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1
|
PT2285408T
(pt)
|
2008-06-05 |
2019-02-01 |
Ablynx Nv |
Sequências de aminoácidos dirigidas contra proteínas de envelope de um vírus e polipéptidos que as compreendem para o tratamento de doenças virais
|
SG192501A1
(en)
|
2008-07-11 |
2013-08-30 |
Medimmune Llc |
Influenza hemagglutinin and neuraminidase variants
|
JP2011528902A
(ja)
*
|
2008-07-25 |
2011-12-01 |
インスティテュート・フォー・リサーチ・イン・バイオメディシン |
抗a型インフルエンザウイルス中和抗体およびその使用
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
US20120128684A1
(en)
|
2008-08-25 |
2012-05-24 |
Burnham Institute For Medical Research |
Conserved Hemagglutinin Epitope, Antibodies to the Epitope and Methods of Use
|
US20100061995A1
(en)
|
2008-09-08 |
2010-03-11 |
Damian Michael Carragher |
Immunotherapy To Treat Or Prevent Viral Infection
|
GB0818356D0
(en)
|
2008-10-07 |
2008-11-12 |
Istituto Superiore Di Sanito |
Antibodies
|
WO2010040281A1
(zh)
|
2008-10-09 |
2010-04-15 |
厦门大学 |
H5亚型禽流感病毒血凝蛋白的人源化抗体及其用途
|
US9347043B2
(en)
|
2008-10-22 |
2016-05-24 |
Institute For Research In Biomedicine |
Methods for producing antibodies from plasma cells
|
US8540995B2
(en)
|
2008-12-24 |
2013-09-24 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies specific to the fusion peptide from hemagglutinin from influenza A viruses and uses thereof
|
US8975378B2
(en)
|
2008-12-25 |
2015-03-10 |
Osaka University |
Human anti-human influenza virus antibody
|
CA2760553A1
(en)
|
2009-04-30 |
2010-11-04 |
Jr. James E. Crowe |
Monoclonal antibodies to influenza h1n1 virus and uses thereof
|
US8470327B2
(en)
|
2009-05-11 |
2013-06-25 |
Crucell Holland B.V. |
Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereof
|
CN102482345A
(zh)
|
2009-05-13 |
2012-05-30 |
航道生物技术有限责任公司 |
针对流感病毒的中和分子
|
IT1395961B1
(it)
|
2009-06-01 |
2012-11-02 |
Pomona Biotechnologies Llc |
Anticorpi monoclonali come medicamento per il trattamento terapeutico e/o profilattico delle infezioni da virus influenzale a (h1n1) di origine suina (s-oiv)
|
WO2011003100A2
(en)
|
2009-07-02 |
2011-01-06 |
Massachusetts Institute Of Technology |
Compositions and methods for diagnosing and/or treating influenza infection
|
AU2010282415A1
(en)
*
|
2009-08-14 |
2012-03-08 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
WO2011041391A1
(en)
|
2009-09-29 |
2011-04-07 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
EP2486054A4
(en)
|
2009-10-09 |
2013-09-11 |
Univ Emory |
RECOMBINANT ANTIBODIES AGAINST H1N1 INFLUENZA
|
WO2011068143A1
(ja)
|
2009-12-03 |
2011-06-09 |
独立行政法人科学技術振興機構 |
H5亜型インフルエンザウイルスに対する抗体およびその利用
|
JP2013060367A
(ja)
|
2010-01-15 |
2013-04-04 |
Osaka Univ |
抗インフルエンザ抗体及びインフルエンザ検出用デバイス
|
ES2802623T3
(es)
|
2010-01-27 |
2021-01-20 |
Massachusetts Inst Technology |
Agentes polipeptídicos técnicamente diseñados para la neutralización dirigida de amplio espectro de la gripe
|
JPWO2011093217A1
(ja)
|
2010-01-29 |
2013-06-06 |
富士レビオ株式会社 |
抗Pandemic(H1N1)2009抗体及びそれを用いた免疫測定方法
|
JPWO2011096302A1
(ja)
|
2010-02-02 |
2013-06-10 |
国立大学法人名古屋大学 |
薬剤耐性インフルエンザウイルス特異的抗体及びその用途
|
JP2011160681A
(ja)
|
2010-02-05 |
2011-08-25 |
Japan Science & Technology Agency |
A型インフルエンザのヘマグルチニンに対する抗体およびその利用
|
EA201400855A1
(ru)
|
2010-03-08 |
2014-11-28 |
Селлтрион, Инк. |
Моноклональные антитела человека, полученные из в-клеток человека и обладающие нейтрализующей активностью против вирусов гриппа а
|
EP2552485B1
(en)
|
2010-03-26 |
2017-03-08 |
Pomona Ricerca S.r.l. |
Full-length immunoglobulins of the igg isotype capable of recognizing a heterosubtype neutralizing epitope on the hemagglutinin stem region and their use as anti-influenza medicament
|
ES2687706T3
(es)
|
2010-06-17 |
2018-10-26 |
Trellis Bioscience, Llc |
Anticuerpos útiles en la inmunización pasiva contra la gripe
|
AU2011289275A1
(en)
|
2010-08-12 |
2013-02-21 |
Theraclone Sciences, Inc. |
Anti-hemagglutinin antibody compositions and methods of use thereof
|
US8992929B2
(en)
|
2010-08-23 |
2015-03-31 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibody specific to major neutralizing epitope of influenza H5 hemagglutinin
|
US9534042B2
(en)
|
2010-09-03 |
2017-01-03 |
Fujita Health University |
Influenza virus-neutralizing antibody and screening method therefor
|
EP2640405A4
(en)
|
2010-09-21 |
2015-04-15 |
Massachusetts Inst Technology |
TREATMENT AND / OR CHARACTERIZATION OF INFLUENZA; POLYPEPTIDES HA ADAPTED TO MAN
|
WO2012045001A2
(en)
|
2010-09-30 |
2012-04-05 |
Vanderbilt University |
Influenza virus antibodies and immunogens and uses therefor
|
US10226527B2
(en)
|
2010-10-04 |
2019-03-12 |
Massachusetts Institute Of Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
WO2012054745A1
(en)
|
2010-10-20 |
2012-04-26 |
New York Blood Center, Inc. |
Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection
|
WO2012072788A1
(en)
|
2010-12-02 |
2012-06-07 |
Mab-Factory Gmbh |
Vaccine against influenza h5n1 viruses, medicament and treatment of h5n1 viral infections
|
US9469685B2
(en)
|
2011-01-10 |
2016-10-18 |
Emory University |
Antibodies directed against influenza
|
EA027054B1
(ru)
|
2011-07-14 |
2017-06-30 |
Круселл Холланд Б.В. |
Связывающие молекулы человека, способные нейтрализовать вирусы гриппа a филогенетической группы 1 и филогенетической группы 2 и вирусы гриппа b
|
SI2734545T1
(sl)
|
2011-07-18 |
2019-06-28 |
Institute For Research In Biomedicine |
Protitelesa, ki nevtralizirajo virus influence A in njihova uporaba
|
AU2012289926A1
(en)
|
2011-08-03 |
2014-03-13 |
Children's Medical Center Corporation |
A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin
|
GB201115214D0
(en)
|
2011-09-02 |
2011-10-19 |
Health Prot Agency |
Influenza virus antibody compositions
|
CN103030693B
(zh)
|
2011-09-30 |
2015-03-11 |
中国科学院上海巴斯德研究所 |
高致病性禽流感的中和分子及其制备方法
|
ES2641257T3
(es)
|
2011-09-30 |
2017-11-08 |
Celltrion, Inc. |
Molécula de unión que tiene actividad neutralizadora contra el virus de la influenza A producida a partir de células B humanas
|
AU2012326025B2
(en)
|
2011-10-18 |
2017-08-31 |
Emory University |
Antibodies directed against influenza
|
KR20130059721A
(ko)
|
2011-11-29 |
2013-06-07 |
(주)셀트리온 |
인간 b 세포에서 생산된 인플루엔자 a 바이러스 중화 활성을 가지는 결합 분자
|
JP6325451B2
(ja)
|
2011-12-02 |
2018-05-16 |
アイム・セラピューティクス・べー・フェー |
A型インフルエンザに特異的な抗体
|
WO2013086052A2
(en)
|
2011-12-05 |
2013-06-13 |
Trellis Bioscience, Llc |
Antibodies useful in passive influenza immunization
|
KR101749316B1
(ko)
|
2011-12-15 |
2017-06-21 |
(주) 에이프로젠 |
H1n1―감염된 환자들로부터 유도된 매우 잠재력 있는 넓은-스펙트럼 중화 단일클론 항체 및 이를 포함하는 바이러스의 치료용 조성물
|
EP2814841A4
(en)
|
2012-01-31 |
2015-06-17 |
Univ Osaka |
HUMAN MONOCLONAL ANTIBODIES FOR WIDE PROTECTION AGAINST INFLUENZA B VIRUS AND METHOD OF USE THEREOF
|
MX360056B
(es)
|
2012-03-08 |
2018-10-19 |
Janssen Vaccines & Prevention Bv |
Moléculas de unión humanas que pueden unirse a los virus de la influenza b y neutralizarlos, y sus usos.
|
EP3492101A3
(en)
|
2012-05-10 |
2019-10-23 |
Massachusetts Institute Of Technology |
Agents for influenza neutralization
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
SG11201505744XA
(en)
|
2013-02-07 |
2015-08-28 |
Massachusetts Inst Technology |
Human adaptation of h5 influenza
|
AU2014329609B2
(en)
|
2013-10-02 |
2019-09-12 |
Humabs Biomed Sa |
Neutralizing anti-influenza A antibodies and uses thereof
|
RU2682049C2
(ru)
|
2014-01-27 |
2019-03-14 |
Дженентек, Инк. |
Лечение вируса гриппа а h7n9
|
WO2017083627A1
(en)
|
2015-11-13 |
2017-05-18 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
EP3419663A1
(en)
|
2016-02-24 |
2019-01-02 |
Visterra, Inc. |
Formulations of antibody molecules to influenza virus
|